Introduction {#sec1-1}
============

*Kati Graha* as a separate disease has been described in the classical text *Gada Nigraha*. It has been correlated in the present study with Lumbar Spondylosis (LS) due to similarity of clinical manifestation and pathogenesis. Low Back Pain (LBP) affects approximately 60-85% of adults during some point in their lives.\[[@ref1]\] LS is responsible for about 10% of all the back pain conditions. As of 2005, lower back pain ranks as number one cause of disability in individuals under the age of 45.\[[@ref2]\] LS is defined broadly as degenerative condition affecting the discs, vertebral bodies, and/or associated joints of the lumbar spine\[[@ref3]\] *Kati Graha* is *Shosha* (degeneration), *Stambha* (stiffness) and *Shula* (pain) predominant *Vyadhi* (disease). As correctly said by *Sushruta Acharya* without vitiation of *Vata*, *Shula* cannot be produced. *Gada Nigraha* clearly states that pain is produced due to stiffness which is produced by *Sama* (with *Ama*) or *Nirama* (without *Ama*) *Vayu* movement into *Kati* (lumbar region) hence this suggests of presence of *Dhatu Kshayatmaka* (degenerative) and *Marga Avarodhaka* (obstructive) type of *Samprapti* (pathology).

This existence of constant pain urges one to find a remedy. But, there is no current concrete, gold-standard treatment approach to the diverse range of patient presentations of *Kati Graha* (LS) despite substantial research efforts to identify conservative and more invasive methods of managing symptoms and slowing progressive degeneration.\[[@ref4]\]

*Yapana Basti* (medicated enema containing milk, meat soup etc.) which was selected for present study is a mild type of *Niruha* that has *Balya* (strength promoting), *Rasayana* and *Vata Kapha Shamaka* effects. Milk added as adjuvant augments its properties.

Keeping in mind the high prevalence, rate of disability in productive span of life, intensity of symptoms of disease, lack of current effective treatment and considering classical reference of efficacy of *Yapana Basti* in *Kati Graha*, a open label, clinical trial was conducted to assess the efficacy of *Eranda Muladi Yapana Basti* in the management of *Kati Graha* with special reference to LS.

Materials and Methods {#sec1-2}
=====================

Plan of study {#sec2-1}
-------------

An open label clinical trial was conducted, where the patients were given treatment with specific duration with fortnightly follow up. Specific instructions on diet and life style modifications were advised to the patients. Institutional Ethics Committee (IEC) approval was obtained and written consent was taken from the patients prior to the initiation of the study.

Selection of patients {#sec2-2}
---------------------

Patients who report to Outdoor Patient Department (OPD) and Indoor Patient Department (IPD) of Institute for Post Graduate Teaching and Research in Ayurveda, Jamnagar were carefully selected on the basis of diagnostic, inclusion criteria, etc.

### Diagnostic criteria {#sec3-1}

Patients having the clinical picture of progressive spinal stiffness, episodic mechanical back pain (more than 3 months), tenderness or/and numbness, symptoms of acute disc herniation, prolapse with or without nerve root irritation (sciatica) with confirmative degenerative changes on X-rays of lumbar spine (Anterio-Posterior i.e. AP view and Lateral view) and fulfilling the Aberdeen LBP Scale were recruited. Detailed physical examination was carried out to assess the decreased range of mobility.

### Inclusion criteria {#sec3-2}

Patients of either sex between 20 to 65 years of ageFulfilling the diagnostic criteria, having signs and symptoms of *Kati Graha* and radiological early degenerative changesFulfilling the symptoms mentioned in Aberdeen LBP Scale and scoring more than 40 in the scaleWilling to sign the consent for study participationAble and willing to comply the treatment schedule.

### Exclusion criteria {#sec3-3}

Patients having spinal tumor, malignant diseases of the pelvis, tuberculosis of vertebral bodiesRecent lumbar surgery or implanted instrumentation or prosthesesChronic metabolic pathologies, i.e., Ankylosing Spondylosis, Rheumatoid Arthritis, Psoriatic Arthritis, Gouty ArthritisPregnancy, Epilepsy or any other serious systemic illness.

### Investigations {#sec3-4}

Routine haematological, bio-chemical and urine investigations were recorded.

Digital X-ray, AP and lateral view of the lumbar spine were taken.

Selection of the drug/medicines {#sec2-3}
-------------------------------

*Eranda Muladi Yapana Basti:* The ingredients of *Eranda muladi Yapana basti*\[[@ref5]\] along with proportion is placed at [Table 1](#T1){ref-type="table"}.*Ingredients of Anuvasana Basti:* Combination of 100 ml *Murchita Tila Taila* with 5g *Saindhava Lavana* and 5 g *Kalka Dravya* (same *Dravyas* used in *Niruha Basti*) was used for *Anuvasana Basti*.

###### 

Composition of *Eranda Muladi Yapana Basti*

![](AYU-34-36-g001)

Methodology {#sec2-4}
-----------

Drug, dosage and duration : Posology is mentioned at [Table 2](#T2){ref-type="table"}.Table 2PosologyMethod of application of therapy: *Eranda Muladi Yapana BastiPurva Karma:* Patient was given local massage with sesame oil and fomentation with plain steam after observing for symptoms of well digested previous meal.*Pradhana Karma:* After clearing natural urges, patient was instructed to lie on left lateral position and after per rectal examination to eliminate rectal pathologies, luke warm *Basti* material was administered. *Anuvasana Basti* was administered with disposable syringe while *Niruha Basti* was administered with plastic enema can.The patient was asked to lie down in supine position gradually and buttocks were tapped slowly and gently 3-4 times. Patient was instructed to evacuate the material when urge arises. The patients were given a questionnaire after careful instructions, to fill up after each *Basti* session. *Samyak Lakshana* were assessed and observed daily.*Pashchat Karma:* Evacuation time of *Basti* material and untoward effects (if any) were observed and noted. One *Muhurta* (48 min) and three *Yama* (9 h) is the maximum period of time in which the evacuation of *Niruha* and *Anuvasana Basti* respectively should occur. The patients were explained and instructed to adhere to *Pariharya Vishaya* (code of conduct) specifically indicated for *Yapana Basti*.Criteria for assessment:The patients were examined weekly changes in symptoms as well as general condition and following points were taken into consideration for the assessment.Response in clinical features of *Kati Graha* at regular intervalsImprovement in *Roga* along with *Deha*, *Agni* and *Chetasa Bala*Changes in the Oswestry Disability Index (ODI) Scale before and after treatmentChanges in modified Schober\'s test and goniometric measurement for lumbar range of movementsDigital X-ray before and after treatment and changes were assessed using modified Kellegren Lawrance Scale (KL Scale)Visual Analogue Scale (VAS) was used to assess intensity of LBP.

Assessment of Ayurvedic parameters is placed in [Table 3](#T3){ref-type="table"}. Grading of Kellegren and Lawrance Scale is placed at [Table 4](#T4){ref-type="table"}.

###### 

Assessment as per Ayurvedic parameters
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###### 

Kellgren-Lawrence grading scale

![](AYU-34-36-g004)

### Overall assessment of therapy: {#sec3-5}

Along with *Roga*, *Deha*, *Agni* and *Chetas Bala*, the Score on ODI scale, VAS and KL scale put together were used for over all assessment.

Complete remission: 100% relief in chief complaints, relief in associated symptoms along with more than 20 points decrease in ODI scale, more than 5 points reduction in VAS and slight changes in X-rayMarked improvement: Above 75% relief in chief complaints, relief in associated symptoms along with more than 20 points decrease in ODI scale, more than 4 points reduction in VAS and slight changes in X-rayModerate improvement: Above 50% but less than 75% relief in the chief complaints, relief in associated symptoms along with more than 10 points decrease in ODI scale, more than 3 points reduction in VAS and no changes in X-rayImproved: More than 25% but less than 50% relief in the chief complaints with slight presence of associate symptoms along with more than 5 points decrease in ODI scale, more than 2 point reduction in VAS and no improvement in X-rayMild Improvement: Less than 25% relief in the chief complaints with slight improvement in associate symptoms, 5 or less than 5 points decrease in ODI scale, less than 2 points reduction in VAS and no improvement in X-rayUnchanged: No relief in any of the signs and symptoms.

Observations {#sec1-3}
============

In the present study, a total number of 23 patients were registered, out of which 20 patients completed the treatment. Three patients discontinued the treatment; one patient had to leave treatment due to change of residence and others due to personal reasons.

Demographic data {#sec2-5}
----------------

In the present study, maximum number of patients were in age group of 31-40 years (47.83%), females (69.56%), Hindu (86.96%), married (86.96%), house wives (47.83%), uneducated (43.48%), having physical as well as mental work load (52.17%), having physically active life style (73.91%), belonging to lower middle economical status (56.52%) and belonging to urban area (56.52%).

### Dasha Vidha Pariksha {#sec3-6}

In the present study, maximum number of patients were having *Vata Kapha Prakriti* (43.48%), *Madhyama Sara* (65.22%), *Madhyama Samhanana* (65.51%), *Madhyama Satva* (56.52%), *Madhyama Abhyavarana Shakti* (56.52%), *Avara Jarana Shakti* (52.17%), having *Mandagni* (34.78%), *Avara Vyayama Shakti* (65.22%) and *Madhyama Vaya Pramana* (52.17%).

### Nidana {#sec3-7}

Amongst *AharajaNidana*, it was found that consuming potatoes, brinjals, chick peas and green peas is habitual in all the registered patients. Similarly, Bakery items were consumed by 65.2% and carbonized drinks were consumed by 69.56%. Incompatible food was consumed by 89.96%. Maximum patients have the habit of consuming spicy food (73.91%). Amongst *Viharaja Nidana*, maximum number of patients had history of faulty posture (78.26%), 82.6% had history of *Ratri Jagarana* (late night sleeping), excessive work load (91.3%) and 95.65% had history of insufficient water intake.

*Chinta* (worrying) was the *Manasika Nidana* amongst most of the patients (91.3%) found in present study followed by *Shoka* (grief) in 34.78% of patients. Sudden jerks to the lumbar spine (69.56%), falls by slipping on wet floor etc., (39.13%) and vital trauma, like spinal anesthesia (13.04%) were found in the patients. Maximum chronicity was 1-3 years (52.17%) in these patients. In the present study, intake of Non Steroidal Anti Inflammatory Drugs (NSAIDS) (91.3%) and analgesics (82.6%) was found in maximum number of patients followed by oral Ayurvedic medicines in 69.56% of patients.

In the present study, 56.52% of patients were having *Vata Kapha Anubandha Samprapti*. The predominant *Dosha* vitiated was *Vata Dosha* (100%). Symptoms of *Rasavaha*, *Asthivaha* and *Udakavaha Sroto Dushti* was found in 100% of patients, *Raktavaha Dushti* was found in 91.3%, *Mamsavaha Dushti* was found in 82.6%, *MedavahaDushti* was found in 26.08%, *Majjavaha Dushti* was found in 95.65% and *Purishavaha Sroto Dushti* was found in 91.3% of the patients respectively.

Parameters related to Eranda Muladi Yapana Basti {#sec2-6}
------------------------------------------------

The average retention time for *Anuvasana Basti* on day one was 2 h where as it was 3.25 h, 4 h, 5.05 h, 5.85, 5.95 h, 4.7 h, 3.95 h and 3.4 h respectively on 3^rd^, 5^th^, 7^th^, 9^th^, 11^th^, 13^th^, 14^th^ and 15^th^ day.

The average retention time for *Niruha Basti* on second day was 4.95 min where as it was 7.9 min on 4^th^ day, 12.2 min on 6^th^ day, 12.65 min on 8^th^ day, 8.9 min on 10^th^ day and 5.9 min on 12^th^ day. The average amount of *Niruha* retained by patients on day 2^nd^, 4^th^, 6^th^, 8^th^, 10^th^ and 12^th^ day was 355 ml, 408 ml, 443 ml, 512 ml, 541 ml and 551 ml respectively.

Result {#sec1-4}
======

Effect of *Eranda Muladi Yapana Basti* {#sec2-7}
--------------------------------------

### Effect on Roga Bala {#sec3-8}

*Eranda Muladi Yapana Basti* provided statistically highly significant (*P* \< 0.001) effect on improving *Kati Graha* (back stiffness), *Kati Shula* (back pain), *Sparsha Asahyata* (tenderness), *Gridrasivat Pida* (sciatic pain), Straight Leg Raise (SLR) test, *Pada Harsha* (tingling sensation in feet), *Pada Gaurava* (heaviness in feet), *Mamsa Bala Kshaya* (decreased muscle strength), *Gamane Kashtata* (difficulty in movements). Insignificant relief was found in producing relief in symptoms of *Pada Supti* (numbness in feet), *Pada Daha* (burning sensation in feet) and *Mamsa Kshaya* (muscle wasting) (*P* \< 0.05). The frequency of pain killers was reduced to statistically significant level \[[Table 5](#T5){ref-type="table"}\].

###### 

Effect on *Roga Bala* (*n*=20)
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### Effect on Agni, Deha and Chetasa Bala {#sec3-9}

*Eranda Muladi Yapana Basti* provided statistically highly significant (*P* \< 0.001) results in all the considered parameters of *Agni*, *Deha* and *Chetasa Bala* \[[Table 6](#T6){ref-type="table"}\].

###### 

Effect on *Agni*, *Deha* and *Chetasa Bala* (*n*=20)

![](AYU-34-36-g006)

### Effect on Doshika Lakshana {#sec3-10}

*Eranda Muladi Yapana Basti* treatment provided statistically highly significant results in reducing *Vata Vriddhi* and *Kapha Vriddhi* (*P* \< 0.001)

### Effect on ODI Scale {#sec3-11}

*Eranda Muladi Yapana Basti* provided statistically highly significant (*P* \< 0.001) results in improving all the given parameters like pain intensity, personal care as well as physical parameters in ODI scale \[[Figure 1](#F1){ref-type="fig"}\].

![Improvement in ODI scale in 20 patients](AYU-34-36-g007){#F1}

### Effect on objective criteria {#sec3-12}

In *Basti* group, though the values were statistically insignificant on KL scale on radiographs of 3 patients disc size improvement was noted thereby reducing the mild spondylotic changes to minimal spondylotic changes which was confirmed by the radiologist. Improvement in the pain related symptoms were statistically highly significant (*P* \< 0.001) as per the VAS \[[Figure 2](#F2){ref-type="fig"}\].

![Effect on objective criteria and ROM in 20 patients](AYU-34-36-g008){#F2}

Over all effect of the therapy {#sec2-8}
------------------------------

In present study, 35% of patients achieved marked improvement, 25% of patients achieved mild improvement and 15% of patients had complete remission and moderate improvement each and10% of the patients showed improved state.

Follow up {#sec2-9}
---------

Maximum (73.53%) patients reported no recurrence of disease during one month follow up while 26.47% of patients noticed recurrence.

Discussion {#sec1-5}
==========

The improvement in the symptoms of *Kati Graha* can be attributed to two major factors i.e. reduction of pain in spine that may be due to analgesic and anti-inflammatory effect of drugs or/and due to increased nourishment to the spine which helps in improving disc size. Pain is inherent quality of *Vata*. Most of the drugs were *Vata Kapha Shamaka* having hot potency and oleation property there by pacify aggrevated Vata. Further, these improve the function of *Vyana Vayu* specifically which is responsible for the movements. In the current pathogenesis it is clearly seen that sciatica (*Gridrasivat Pida*) is a symptom at the 3^rd^ stage of degenerative cascade\[[@ref6]\] model where nerve impingement takes place. The symptoms like *Pada Harsha*, *Pada Gaurava*, *Pada Supti* of radiculopathy may have reduced due to reduction of inflammation.

With the treatment, one patient had eight times bowel movements after initial *Niruha* but after proper rehydration measures, the patient was able to under go remaining course of *Basti*. The first *Basti* may act as natural cleansing agent (*Koshta Shuddhi*) in this patient who was of *Mridu Koshtha* (sensitive bowel).

Conclusion {#sec1-6}
==========

Thus it can be clearly seen that *Eranda Muladi Yapana Basti* holds promising hope as non-invasive intervention in the management of *Kati Graha* w.s.r. to LS.

*Eranda Muladi Yapana Basti* yields better results in pacifying pure *Vataja* or *Vata Kaphaja* type of *Kati Graha*. In *Pitta Prakriti* patients, symptoms may aggravate due to *Ushna Virya* property of ingredients. *Yapana Basti* is a good alternative to classical *Dvadasha Prastriti Niruha* etc., which is not well tolerated by today\'s delicate and weak patients. Further, mild restricted code of conduct makes it an ideal therapy for today\'s fast paced society.
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